Followers | 471 |
Posts | 29503 |
Boards Moderated | 1 |
Alias Born | 11/12/2016 |
Friday, November 13, 2020 5:28:01 PM
.003 to .0718 run was 24 bags !!!
Ouch to peeps who sold and left 2400% gains on the table
One must do his own DD
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158972930
I am Expecting another such move very soon !
connect the dots ...
Ridgeway accepted 65m common shares restricted for 6months for a reason
Ridgeway approved the AS increase as a majority holder on October 6th per pre 14c filing !!!
Something is cooking
Connect the dots, ignore the noise
Current Float only 55-85 million
Any news will make this go parabolic
$NSPX Excellent debt renegotiation at very favourable conditions ...
https://www.otcmarkets.com/filing/html?id=14468027&guid=lGDeUehJ9iZAs3h
“Item 1.01 Entry into a Material Definitive Agreement.
On October 23, 2020, Inspyr Therapeutics, Inc. (“Company”) sold an aggregate of $600,000 of senior convertible debentures (“Debentures”) for (i) $500,000 in cash and (ii) $100,000 in cancellation of outstanding indebtedness to existing accredited and institutional investors (the “Investors”) of the Company.
The Debentures (i) are non-interest bearing, (ii) have a maturity date of October 23, 2021, (iii) are convertible into shares of common stock (“Common Stock”) of the Company at the election of the Investors at any time, subject to a beneficial ownership limitation of 9.99%, and (iv) have a conversion price equal to the lesser of $0.02 and 85% of the lesser of (a) the volume weighted average price on the trading day immediately preceding a conversion date and (b) the volume weighted average price on a conversion date.”
$NSPX From DEF14c filing
https://www.otcmarkets.com/filing/html?id=14479311&guid=GTVeUnCYhB1jNyh
”Upon the effectiveness of the Amended Certificate, the Company may explore additional financing opportunities or strategic transactions that would require the issuance of additional shares of Common Stock, but no such plans are currently in existence and the Company has not begun any negotiations with any party related thereto.”
Recent RBSH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:19:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:36:33 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM